These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20932148)

  • 41. Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium.
    Ashizuka S; Inagaki-Ohara K; Kuwasako K; Kato J; Inatsu H; Kitamura K
    Microbiol Immunol; 2009 Oct; 53(10):573-81. PubMed ID: 19780971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on mucosal immunoglobulin A in gastrointestinal disease.
    Brandtzaeg P
    Curr Opin Gastroenterol; 2010 Nov; 26(6):554-63. PubMed ID: 20693891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Innate antimicrobial immunity in inflammatory bowel diseases.
    Beisner J; Stange EF; Wehkamp J
    Expert Rev Clin Immunol; 2010 Sep; 6(5):809-18. PubMed ID: 20828289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunity, inflammation, and allergy in the gut.
    Macdonald TT; Monteleone G
    Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelial barriers in intestinal inflammation.
    John LJ; Fromm M; Schulzke JD
    Antioxid Redox Signal; 2011 Sep; 15(5):1255-70. PubMed ID: 21294654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enterocyte death and intestinal barrier maintenance in homeostasis and disease.
    Vereecke L; Beyaert R; van Loo G
    Trends Mol Med; 2011 Oct; 17(10):584-93. PubMed ID: 21741311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury.
    Wang J; Hauer-Jensen M
    Br J Radiol; 2007 Sep; 80 Spec No 1():S41-8. PubMed ID: 17704325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal barrier homeostasis in inflammatory bowel disease.
    Goll R; van Beelen Granlund A
    Scand J Gastroenterol; 2015 Jan; 50(1):3-12. PubMed ID: 25523551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The intestinal epithelial barrier in the control of homeostasis and immunity.
    Rescigno M
    Trends Immunol; 2011 Jun; 32(6):256-64. PubMed ID: 21565554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of programmed necrosis and cell death in intestinal inflammation.
    Dagenais M; Douglas T; Saleh M
    Curr Opin Gastroenterol; 2014 Nov; 30(6):566-75. PubMed ID: 25291357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enteric glial cells: recent developments and future directions.
    Neunlist M; Rolli-Derkinderen M; Latorre R; Van Landeghem L; Coron E; Derkinderen P; De Giorgio R
    Gastroenterology; 2014 Dec; 147(6):1230-7. PubMed ID: 25305504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome.
    Santos J; Alonso C; Vicario M; Ramos L; Lobo B; Malagelada JR
    Curr Mol Med; 2008 Jun; 8(4):258-73. PubMed ID: 18537634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease.
    Deuring JJ; de Haar C; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
    Int J Biochem Cell Biol; 2013 Apr; 45(4):798-806. PubMed ID: 23291352
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and disease.
    Meir M; Flemming S; Burkard N; Wagner J; Germer CT; Schlegel N
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1118-23. PubMed ID: 27151942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leaky gut - concept or clinical entity?
    Quigley EM
    Curr Opin Gastroenterol; 2016 Mar; 32(2):74-9. PubMed ID: 26760399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Good bug, bad bug: in the case of enteric inflammatory disease does the epithelium decide?
    McKay DM
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():205-10. PubMed ID: 15962124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal permeability--a new target for disease prevention and therapy.
    Bischoff SC; Barbara G; Buurman W; Ockhuizen T; Schulzke JD; Serino M; Tilg H; Watson A; Wells JM
    BMC Gastroenterol; 2014 Nov; 14():189. PubMed ID: 25407511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune-non immune networks in intestinal inflammation.
    Hausmann M; Rogler G
    Curr Drug Targets; 2008 May; 9(5):388-94. PubMed ID: 18473767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated apoptosis impairs epithelial cell turnover and shortens villi in TNF-driven intestinal inflammation.
    Parker A; Vaux L; Patterson AM; Modasia A; Muraro D; Fletcher AG; Byrne HM; Maini PK; Watson AJM; Pin C
    Cell Death Dis; 2019 Feb; 10(2):108. PubMed ID: 30728350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.